Benzimidazolone derivatives as bromodomain inhibitors
US9255089B2 · kind B2 · utility
7Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2014 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Apr 19, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, a bromodomain-containing protein, including bromodomain-containing protein 4 (BRD4), and to compositions and formulations containing such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I)wherein R1a, R1b, R2a, R2b, R3, and X are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.